EyePoint, Inc. (EYPT)
4.23
-0.02
(-0.47%)
USD |
NASDAQ |
Sep 11, 16:00
4.225
0.00 (0.00%)
After-Hours: 20:00
EyePoint Enterprise Value : 201.37M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 201.37M |
| September 10, 2026 | 203.07M |
| September 09, 2026 | 210.72M |
| September 08, 2026 | 229.41M |
| September 04, 2026 | 231.11M |
| September 03, 2026 | 229.84M |
| September 02, 2026 | 248.96M |
| September 01, 2026 | 231.11M |
| August 31, 2026 | 224.31M |
| August 28, 2026 | 222.61M |
| August 27, 2026 | 235.36M |
| August 26, 2026 | 265.95M |
| August 25, 2026 | 267.23M |
| August 24, 2026 | 255.76M |
| August 21, 2026 | 294.00M |
| August 20, 2026 | 300.80M |
| August 19, 2026 | 377.28M |
| August 18, 2026 | 306.75M |
| August 17, 2026 | 255.76M |
| August 14, 2026 | 1.095B |
| August 13, 2026 | 987.45M |
| August 12, 2026 | 991.70M |
| August 11, 2026 | 950.91M |
| August 10, 2026 | 952.61M |
| August 07, 2026 | 1.022B |
| Date | Value |
|---|---|
| August 06, 2026 | 932.21M |
| August 05, 2026 | 882.92M |
| August 04, 2026 | 833.63M |
| August 03, 2026 | 897.37M |
| July 31, 2026 | 882.92M |
| July 30, 2026 | 934.76M |
| July 29, 2026 | 854.88M |
| July 28, 2026 | 858.28M |
| July 27, 2026 | 896.52M |
| July 24, 2026 | 877.82M |
| July 23, 2026 | 901.62M |
| July 22, 2026 | 917.76M |
| July 21, 2026 | 950.91M |
| July 20, 2026 | 917.76M |
| July 17, 2026 | 972.15M |
| July 16, 2026 | 950.06M |
| July 15, 2026 | 1.019B |
| July 14, 2026 | 1.009B |
| July 13, 2026 | 1.055B |
| July 10, 2026 | 1.093B |
| July 09, 2026 | 1.103B |
| July 08, 2026 | 1.032B |
| July 07, 2026 | 1.033B |
| July 06, 2026 | 1.069B |
| July 02, 2026 | 1.030B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ocular Therapeutix, Inc. | 1.784B |
| Eli Lilly & Co. | 1.096T |
| Elanco Animal Health, Inc. | 14.96B |
| Amylyx Pharmaceuticals, Inc. | 3.276B |
| Nuvation Bio, Inc. | 1.879B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -94.47M |
| Revenue (Quarterly) | 0.507M |
| Total Expenses (Quarterly) | 94.98M |
| EPS Diluted (Quarterly) | -1.092 |
| Gross Profit Margin (Quarterly) | -36.09% |
| Profit Margin (Quarterly) | -18.63K% |
| Earnings Yield | -88.50% |
| Normalized Earnings Yield | -88.50 |